By
Morocco is one of the most commercially and clinically interesting rehabilitation markets in North Africa, yet it is still under-profiled in many O&P discussions.
With a population of 37.7 million in 2023, current health expenditure of 5.74% of GDP, and lower-middle-income status, Morocco combines scale, urban concentration, and a rising chronic disease burden in a way that creates meaningful long-term opportunity for prosthetics, orthotics, rehabilitation, and assistive technology providers.
For the O&P sector, Morocco’s demand profile is being driven less by large-scale conflict trauma and more by noncommunicable diseases, ageing, stroke, diabetes, musculoskeletal conditions, and road injury. WHO EMRO reported in September 2025 that noncommunicable diseases account for nearly 85% of all deaths in Morocco, including 24% of deaths among people aged 30 to 70. The same WHO summary said 94.3% of adults in the national STEPS survey had at least one NCD risk factor, while 10.6% had diabetes, 10.4% were pre-diabetic, 53% were overweight, and 20% were obese.
That matters because Morocco’s future rehabilitation burden will increasingly be shaped by chronic disease complications rather than by acute episodic care alone. For IMEA CPO readers, this translates into rising need for diabetic foot pathways, orthotic offloading, custom footwear, stroke-related bracing, mobility aids, neurorehabilitation support, and selected prosthetic services. This is an inference from the WHO disease burden and risk-factor profile, but it is a strong one given the known downstream link between diabetes, stroke, disability, and rehabilitation demand.
Why Morocco matters for prosthetics and orthotics
The single clearest O&P growth area in Morocco is diabetic foot care and limb preservation. According to the IDF Diabetes Atlas 11th edition, Morocco had an estimated 2.88 million adults aged 20–79 living with diabetes in 2024, with an age-standardised prevalence of 11.9%. The IDF also estimates that 31.7% of people with diabetes in Morocco remain undiagnosed, while diabetes-related health expenditure reached about USD 1.31 billion in 2024. Projections suggest the number of adults with diabetes could rise to 4.24 million by 2050.
For the O&P market, those numbers point directly to demand for:
- custom diabetic insoles
- pressure-relieving foot orthoses
- protective footwear
- walking aids
- rigid removable offloading devices
- post-amputation prosthetic rehabilitation
WHO has explicitly highlighted that people living with diabetes often need rehabilitation and assistive products such as therapeutic footwear, walking aids, and offloading devices to reduce complications including lower-limb amputation.
This creates a particularly strong commercial case for providers that can combine screening, education, orthotic intervention, footwear, and referral pathways, rather than focusing only on late-stage device supply. In practical terms, Morocco looks more attractive as a limb-preservation and practical orthotics market than as a pure premium prosthetic component market alone. That is an inference, but it is closely aligned with the country’s diabetes and NCD profile.
Rehabilitation demand drivers
Morocco’s rehabilitation economy is also likely to be shaped by stroke, cardiovascular disease, musculoskeletal disability, and road traffic injury. WHO’s country overview includes road traffic deaths as a monitored health indicator, while a 2025 open-access analysis of Moroccan road traffic accidents described them as a “real public health problem” causing major injury and mortality, with young adults particularly affected. That matters for orthotics and rehabilitation because road trauma often generates long-term need for lower-limb bracing, upper-limb splinting, mobility aids, and post-trauma rehabilitation support.
At the same time, Morocco’s health system is under strain. WHO EMRO notes that the country has only 1.5 health care workers per 1,000 people, well below the SDG benchmark of 4.45, while demand for chronic disease care continues to rise. That workforce gap is important for the O&P sector because it increases the value of practical, scalable, protocol-driven rehabilitation and assistive technology services that can extend care capacity rather than rely only on highly specialised centres.
Market characteristics
Morocco has several features that make it commercially appealing. First, it has scale with relatively strong urban concentration, which supports centralized service models and hub-based fabrication. Second, the country is moving through a broad health reform phase. The World Bank said in March 2025 that Morocco is advancing toward universal health coverage, with around 75% of the population effectively covered at that point, while reforms aim to expand mandatory health insurance, modernize service delivery, and improve equitable workforce distribution. Morocco later became one of the countries launching a National Health Compact with the World Bank in December 2025, reinforcing the reform trajectory.
That reform context matters for IMEA CPO readers because it suggests a healthcare environment where rehabilitation, assistive technology, and orthotic services could increasingly align with wider public-system modernization. It does not guarantee rapid O&P procurement growth, but it does improve the strategic case for companies and clinics that can position themselves within broader health-system strengthening rather than only as niche device suppliers. This is an inference based on Morocco’s UHC reforms and health-system restructuring.
A further point in Morocco’s favour is the visibility of disability and inclusion policy. Public reporting in late 2024 indicated new Moroccan budget commitments to disability support programmes, including technical and medical aid for people with disabilities. I would treat those figures cautiously because the source available here is a media report rather than a primary ministry budget document, but the broader signal is still relevant: disability support and assistive access appear to be receiving more policy attention.
Key opportunities for IMEA CPO readers
Diabetic foot and limb preservation
This looks like the strongest near-term opportunity. Morocco’s diabetes burden is already large and projected to rise, while WHO has specifically linked diabetes care to rehabilitation and assistive technology needs such as therapeutic footwear and walking aids. Clinics and suppliers that build preventive pathways rather than waiting for ulceration and amputation are likely to be better positioned.
Stroke and neuro orthotics
Morocco’s NCD-heavy profile supports likely growth in demand for AFOs, hand splints, mobility devices, and rehabilitation-linked orthotic care. The opportunity here is less about high-end novelty and more about practical, repeatable functional support integrated into rehab pathways. This is an inference from the NCD burden and rehabilitation demand pattern.
Assistive technology integration
WHO continues to frame assistive technology and rehabilitation as essential parts of care for chronic disease and disability. In Morocco, the shortage of health workers and rising chronic disease burden strengthen the case for scalable assistive pathways that help extend functional care into the community and outpatient environment.
Regional North Africa positioning
For companies seeking a North African foothold, Morocco offers a more diversified and reform-oriented environment than some neighbouring markets, with a large urban population and visible health-system modernization. That makes it attractive for value-focused orthotics, diabetic care, mobility aids, and rehabilitation support models. This is a strategic inference based on the country’s population, reform momentum, and disease burden.
Main constraints
The challenges are real. Morocco’s public health sector continues to face structural pressure, including workforce shortages, regional disparities, and hospital infrastructure gaps. Public reporting in 2025 highlighted a national plan to rehabilitate 83 hospitals, underlining both the scale of need and the government’s acknowledgement that health infrastructure still requires major strengthening. While that article is not a primary source, it is broadly consistent with the official ministerial reform narrative on Maroc.ma about longstanding system deficiencies and structural reform.
For O&P businesses, that means success in Morocco is likely to depend on:
- strong value positioning
- alignment with public and mixed-pay pathways
- clinician education
- integration into diabetes and rehabilitation care models
- evidence of functional benefit and complication reduction
That final point is an inference, but it follows directly from Morocco’s disease burden, workforce constraints, and UHC-focused reform environment.
Bottom line
Morocco is one of the stronger under-watched rehabilitation and O&P markets in North Africa: large enough to matter, reforming enough to watch closely, and increasingly shaped by diabetes and chronic disease rather than only by conventional trauma narratives. For IMEA CPO readers, the most promising opportunities appear to be in diabetic foot care, practical orthotics, assistive technology, and rehabilitation-linked mobility support, rather than in a narrow premium-import strategy alone. It is a market where need is rising, policy attention is increasing, and clinically grounded providers with the right product mix could build durable positions.
